Physician profile
John Baker
NPI 1043294663
$10,529.97
in general payments reported to CMS, 2019-2025
27 companies · $541 in 2025
The $541 reported for 2025 was more than what a typical Vascular Neurology provider received nationally (typical 2025 total: $360).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,645 · 2020: $407 · 2021: $3,750 · 2022: $1,154 · 2023: $1,980 · 2024: $1,052 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,601 · Travel and Lodging: $972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,601.26 |
| Travel and Lodging | $972.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $3,579.27 | 2020-2022 | |
| Stryker Corporation | $2,097.74 | 2019-2023 | Power-Pro, Target, Surpass Evolve |
| Medtronic USA, INC. | $1,854.09 | 2019-2020 | |
| Medtronic, INC. | $745.53 | 2021-2025 | Pipeline, Rist, Onyx 18 |
| Penumbra, INC. | $605.50 | 2022-2025 | Penumbra System, Benchmark, Red 72 |
| Imperative Care, INC | $369.99 | 2021-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Rapid Medical Ltd | $288.10 | 2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Depuy Synthes Sales INC. | $250.84 | 2021-2024 | Cerebase, Embotrap, Trufill |
| Eisai INC. | $124.93 | 2024 | |
| Mallinckrodt Hospital Products INC. | $96.53 | 2024 | Acthar |
| Cordis US Corp. | $88.00 | 2021 | |
| Shockwave Medical, INC | $72.59 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Ucb, INC. | $49.30 | 2023-2024 | Briviact |
| Microvention, INC. | $42.05 | 2025 | Balloon Catheter, Web Aneurysm Embolization System |
| Balt USA, LLC | $32.59 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.18 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $23.93 | 2022 | |
| Abbott Laboratories | $23.83 | 2021 | |
| Amgen INC. | $23.22 | 2021 | |
| Haemonetics Corporation | $22.79 | 2024 | Teg6s Hemostasis System |
| Medical Device Business Services, INC. | $19.62 | 2022 | |
| Greenwich Biosciences, INC. | $19.53 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $18.69 | 2021 | |
| Asahi Intecc USA, INC. | $15.47 | 2024 | Peripheral Vascular |
| Ge Healthcare | $14.79 | 2019 | |
| Ceribell, INC. | $13.27 | 2020 | |
| Livanova USA, INC. | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.